ExoVasc® PEARS

Royal Brompton Hospital approves device

Share:

Following the completion of the initial clinical trial the Clinical Practice Committee at the Royal Brompton Hospital has approved the device for use in the treatment of suitable patients with a dilated aorta due to Marfan syndrome

Share:

Related articles

Exstent receives Cyber Essentials certification

SME News, Managing Director of the Year Awards

Interested in our patient experiences?